These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 26003861)

  • 41. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.
    Tang X; Holland D; Dale AM; Younes L; Miller MI;
    Hum Brain Mapp; 2014 Aug; 35(8):3701-25. PubMed ID: 24443091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.
    Caroli A; Prestia A; Wade S; Chen K; Ayutyanont N; Landau SM; Madison CM; Haense C; Herholz K; Reiman EM; Jagust WJ; Frisoni GB;
    Alzheimer Dis Assoc Disord; 2015; 29(2):101-9. PubMed ID: 25437302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
    Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
    Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
    Parnetti L; Chiasserini D; Eusebi P; Giannandrea D; Bellomo G; De Carlo C; Padiglioni C; Mastrocola S; Lisetti V; Calabresi P
    J Alzheimers Dis; 2012; 29(1):229-38. PubMed ID: 22232006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can a Novel High-Density EEG Approach Disentangle the Differences of Visual Event Related Potential (N170), Elicited by Negative Facial Stimuli, in People with Subjective Cognitive Impairment?
    Lazarou I; Adam K; Georgiadis K; Tsolaki A; Nikolopoulos S; Yiannis Kompatsiaris I; Tsolaki M
    J Alzheimers Dis; 2018; 65(2):543-575. PubMed ID: 30103320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The free and cued selective reminding test: Validation for mild cognitive impairment and Alzheimer's disease.
    Lemos R; Simões MR; Santiago B; Santana I
    J Neuropsychol; 2015 Sep; 9(2):242-57. PubMed ID: 24894485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
    Barone E; Di Domenico F; Cenini G; Sultana R; Coccia R; Preziosi P; Perluigi M; Mancuso C; Butterfield DA
    J Alzheimers Dis; 2011; 25(4):623-33. PubMed ID: 21483094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
    J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
    Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
    J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global N-acetylaspartate in normal subjects, mild cognitive impairment and Alzheimer's disease patients.
    Glodzik L; Sollberger M; Gass A; Gokhale A; Rusinek H; Babb JS; Hirsch JG; Amann M; Monsch AU; Gonen O
    J Alzheimers Dis; 2015; 43(3):939-47. PubMed ID: 25125458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
    Bradburn S; Murgatroyd C; Ray N
    Ageing Res Rev; 2019 Mar; 50():1-8. PubMed ID: 30610927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer's disease with disease-related biomarkers.
    Ivanoiu A; Dricot L; Gilis N; Grandin C; Lhommel R; Quenon L; Hanseeuw B
    J Alzheimers Dis; 2015; 43(3):835-47. PubMed ID: 25114071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The emerging role of glutathione in Alzheimer's disease.
    Saharan S; Mandal PK
    J Alzheimers Dis; 2014; 40(3):519-29. PubMed ID: 24496077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
    Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
    Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accuracy of verbal fluency tests in the discrimination of mild cognitive impairment and probable Alzheimer's disease in older Spanish monolingual individuals.
    García-Herranz S; Díaz-Mardomingo MC; Venero C; Peraita H
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 Nov; 27(6):826-840. PubMed ID: 31822214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
    Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.